Cargando…

A Clinical Scoring System for Diagnosis of Ocular Demodicosis

BACKGROUND: Demodex may cause chronic and refractory blepharitis with associated ocular surface problems, and its diagnosis and treatment can be quite challenging. In this study, our aim was to assess the efficacy of tea tree oil in Demodex treatment on caucasian patients in an industrialized region...

Descripción completa

Detalles Bibliográficos
Autores principales: Alver, Oktay, Kıvanç, Sertaç Argun, Budak, Berna Akova, Tüzemen, Nazmiye Ülkü, Ener, Beyza, Özmen, Ahmet Tuncer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733813/
https://www.ncbi.nlm.nih.gov/pubmed/29224027
http://dx.doi.org/10.12659/MSM.907824
_version_ 1783286944144293888
author Alver, Oktay
Kıvanç, Sertaç Argun
Budak, Berna Akova
Tüzemen, Nazmiye Ülkü
Ener, Beyza
Özmen, Ahmet Tuncer
author_facet Alver, Oktay
Kıvanç, Sertaç Argun
Budak, Berna Akova
Tüzemen, Nazmiye Ülkü
Ener, Beyza
Özmen, Ahmet Tuncer
author_sort Alver, Oktay
collection PubMed
description BACKGROUND: Demodex may cause chronic and refractory blepharitis with associated ocular surface problems, and its diagnosis and treatment can be quite challenging. In this study, our aim was to assess the efficacy of tea tree oil in Demodex treatment on caucasian patients in an industrialized region of Turkey, and to develop a systematic scoring system for extremely accurate diagnosis in the absence of advanced facilities. MATERIAL/METHODS: Charts of 412 patients with blepharitis were reviewed. A group of 39 out of 412 cases were identified as chronic and treatment-refractory, and therefore were enrolled in this study. Eyelashes from each of the lower and upper eyelids of both eyes were evaluated at ×40 and ×100 magnification using light microscopy. Treatment was started with 4% tea tree oil eyelid gel and 10% eyelash shampoo. Symptoms and findings were scored according to the most common complaints. RESULTS: The mean age of the patients was 54.1±15.4 years. Seventeen (43.5%) patients were male and 22 (56.5%) patients were female. In 30 out of the 39 patients (76.9%) D. folliculorum was detected. Symptoms disappeared in 25 patients. The mean score of patients who were Demodex-negative was 2.7±1.0, and the mean score of patients who were Demodex-positive was 3.8±1.6 (p=0.047). Ninety-four percent of those with a score of 4 and over were found to be Demodex-positive (p=0.025). CONCLUSIONS: Treatment with tea tree oil can be successful. If there is no facility to identify Demodex under light microscopy, we recommend starting treatment for patients who have scores of 4 and over using the scoring chart developed in this study.
format Online
Article
Text
id pubmed-5733813
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-57338132017-12-20 A Clinical Scoring System for Diagnosis of Ocular Demodicosis Alver, Oktay Kıvanç, Sertaç Argun Budak, Berna Akova Tüzemen, Nazmiye Ülkü Ener, Beyza Özmen, Ahmet Tuncer Med Sci Monit Clinical Research BACKGROUND: Demodex may cause chronic and refractory blepharitis with associated ocular surface problems, and its diagnosis and treatment can be quite challenging. In this study, our aim was to assess the efficacy of tea tree oil in Demodex treatment on caucasian patients in an industrialized region of Turkey, and to develop a systematic scoring system for extremely accurate diagnosis in the absence of advanced facilities. MATERIAL/METHODS: Charts of 412 patients with blepharitis were reviewed. A group of 39 out of 412 cases were identified as chronic and treatment-refractory, and therefore were enrolled in this study. Eyelashes from each of the lower and upper eyelids of both eyes were evaluated at ×40 and ×100 magnification using light microscopy. Treatment was started with 4% tea tree oil eyelid gel and 10% eyelash shampoo. Symptoms and findings were scored according to the most common complaints. RESULTS: The mean age of the patients was 54.1±15.4 years. Seventeen (43.5%) patients were male and 22 (56.5%) patients were female. In 30 out of the 39 patients (76.9%) D. folliculorum was detected. Symptoms disappeared in 25 patients. The mean score of patients who were Demodex-negative was 2.7±1.0, and the mean score of patients who were Demodex-positive was 3.8±1.6 (p=0.047). Ninety-four percent of those with a score of 4 and over were found to be Demodex-positive (p=0.025). CONCLUSIONS: Treatment with tea tree oil can be successful. If there is no facility to identify Demodex under light microscopy, we recommend starting treatment for patients who have scores of 4 and over using the scoring chart developed in this study. International Scientific Literature, Inc. 2017-12-10 /pmc/articles/PMC5733813/ /pubmed/29224027 http://dx.doi.org/10.12659/MSM.907824 Text en © Med Sci Monit, 2017 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Clinical Research
Alver, Oktay
Kıvanç, Sertaç Argun
Budak, Berna Akova
Tüzemen, Nazmiye Ülkü
Ener, Beyza
Özmen, Ahmet Tuncer
A Clinical Scoring System for Diagnosis of Ocular Demodicosis
title A Clinical Scoring System for Diagnosis of Ocular Demodicosis
title_full A Clinical Scoring System for Diagnosis of Ocular Demodicosis
title_fullStr A Clinical Scoring System for Diagnosis of Ocular Demodicosis
title_full_unstemmed A Clinical Scoring System for Diagnosis of Ocular Demodicosis
title_short A Clinical Scoring System for Diagnosis of Ocular Demodicosis
title_sort clinical scoring system for diagnosis of ocular demodicosis
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733813/
https://www.ncbi.nlm.nih.gov/pubmed/29224027
http://dx.doi.org/10.12659/MSM.907824
work_keys_str_mv AT alveroktay aclinicalscoringsystemfordiagnosisofoculardemodicosis
AT kıvancsertacargun aclinicalscoringsystemfordiagnosisofoculardemodicosis
AT budakbernaakova aclinicalscoringsystemfordiagnosisofoculardemodicosis
AT tuzemennazmiyeulku aclinicalscoringsystemfordiagnosisofoculardemodicosis
AT enerbeyza aclinicalscoringsystemfordiagnosisofoculardemodicosis
AT ozmenahmettuncer aclinicalscoringsystemfordiagnosisofoculardemodicosis
AT alveroktay clinicalscoringsystemfordiagnosisofoculardemodicosis
AT kıvancsertacargun clinicalscoringsystemfordiagnosisofoculardemodicosis
AT budakbernaakova clinicalscoringsystemfordiagnosisofoculardemodicosis
AT tuzemennazmiyeulku clinicalscoringsystemfordiagnosisofoculardemodicosis
AT enerbeyza clinicalscoringsystemfordiagnosisofoculardemodicosis
AT ozmenahmettuncer clinicalscoringsystemfordiagnosisofoculardemodicosis